North Carolina Extends Prior Authorization for Type 1 Diabetes
In its May 2025 pharmacy update, NC Medicaid has provided notice that prior authorization approval for insulin has been extended for up to 3 years. The notice is below.
Insulin Prior Authorization Extension for Type 1 Diabetes
(Excerpt from NC Medicaid’s May 2025 Pharmacy Newsletter)
Insulin Prior Authorization Extension for Type 1 Diabetes To improve patient access and streamline the prescribing process for NC Medicaid beneficiaries with Type 1 diabetes, prior authorization (PA) approvals for certain insulin products may now be extended for up to 3-years, effective May 1, 2025. This applies to the following specific insulin categories:
- Rapid-acting insulin,
- Short-acting insulin,
- Intermediate-acting insulin,
- Long-acting insulin,
- Premixed rapid combination insulin, and
- Premixed 70/30 combination insulin
All other diabetes diagnoses will continue to have a 1-year prior authorization.
To reach NC Medicaid . . .
NC Medicaid Contact Center – 888-245-0179
Provider Ombudsman – [email protected] | 866-304-7062
NCTracks Call Center – 800-688-6696